University of Nebraska - Lincoln

DigitalCommons@University of Nebraska - Lincoln
Faculty Publications -- Chemistry Department

Published Research - Department of Chemistry

7-2012

Knockdown of the Cellular Protein LRPPRC
Attenuates HIV-1 Infection
Cameron J. Schweitzer
Creighton University School of Medicine

John M. Matthews
Creighton University School of Medicine

Christian J. Madson
Creighton University School of Medicine

Meghan R. Donnellan
Creighton University School of Medicine

Ronald Cerny
University of Nebraska - Lincoln, rcerny1@unl.edu
See next page for additional authors

Follow this and additional works at: http://digitalcommons.unl.edu/chemfacpub
Schweitzer, Cameron J.; Matthews, John M.; Madson, Christian J.; Donnellan, Meghan R.; Cerny, Ronald; and Belshan, Michael,
"Knockdown of the Cellular Protein LRPPRC Attenuates HIV-1 Infection" (2012). Faculty Publications -- Chemistry Department. 62.
http://digitalcommons.unl.edu/chemfacpub/62

This Article is brought to you for free and open access by the Published Research - Department of Chemistry at DigitalCommons@University of
Nebraska - Lincoln. It has been accepted for inclusion in Faculty Publications -- Chemistry Department by an authorized administrator of
DigitalCommons@University of Nebraska - Lincoln.

Authors

Cameron J. Schweitzer, John M. Matthews, Christian J. Madson, Meghan R. Donnellan, Ronald Cerny, and
Michael Belshan

This article is available at DigitalCommons@University of Nebraska - Lincoln: http://digitalcommons.unl.edu/chemfacpub/62

Knockdown of the Cellular Protein LRPPRC Attenuates
HIV-1 Infection
Cameron J. Schweitzer1, John M. Matthews1, Christian J. Madson1, Meghan R. Donnellan1,
Ronald L. Cerny2,3, Michael Belshan1,3*
1 Department of Medical Microbiology and Immunology, Creighton University School of Medicine, Omaha, Nebraska, United States of America, 2 Department of
Chemistry, University of Nebraska-Lincoln, Lincoln, Nebraska, United States of America, 3 The Nebraska Center for Virology, Lincoln, Nebraska, United States of America

Abstract
HIV-1 exploits numerous host cellular pathways for productive infection. To identify novel factors involved in HIV-1
replication, HIV-1 integrase and matrix protein complexes were captured at 4 hours post infection for proteomic analysis
using an affinity purification system. Leucine-rich PPR-motif containing (LRPPRC) protein, a cellular protein involved in
mitochondrial function, cell metabolism, and cell-cycle progression was identified as one of the candidate HIV-1 factors. Coimmunoprecipitation RT-PCR experiments confirmed that LRPPRC associated with HIV-1 nucleic acids during the early steps
of virus infection. To establish if LRPPRC was critical for HIV-1 infection, three independent LRPPRC knockdown cell lines
were constructed (2.7, 3.6, and 4.1). Subcellular fractionation of these cell lines revealed differential knockdown of LRPPRC in
subcellular compartments. LRPPRC was knocked down in the insoluble/cytoskeletal fractions of all three cell lines, but the
3.6 and 4.1 cells also showed a reduction in nuclear LRPPRC. Additionally, several cellular factors were downregulated and/
or disrupted by loss of LRPPRC. HIV-1 infection was reduced in all three cell lines, but virus production and RNA
encapsidation were unaffected, suggesting that LRPPRC was critical for the afferent stage of virus replication. Two of the
three cell lines (3.6, 4.1) were refractory for murine leukemia virus infection, a virus dependent on cellular proliferation for
productive infection. Consistent with this, these two cell lines exhibited reduced cellular growth with no loss of cellular
viability or change in cell cycle phenotype. The early steps of virus infection were also differentially affected among the cell
lines. A reduced level of preintegration complex formation was observed in all three cell lines, but viral DNA nuclear import
was reduced only in the 3.6 and 4.1 cells. Combined, these data identify LRPPRC as a HIV-1 factor that is involved in HIV-1
replication through more than one mechanism.
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among the first viral proteins identified to play a role in HIV-1
preintegration complex nuclear import, its role in the early steps of
virus replication is controversial. MA is a component of both
reverse transcription and preintegration complexes and contains
two putative nuclear localization sequences (NLS) [10]; however,
deletion of these sequences does not ablate the nuclear import
process [11,12,13].
The principle function of IN is facilitating integration of the
vDNA into the host cell chromosome. IN proteins multimerize at
the ends of the newly synthesized vDNA and cleave the two
proximal nucleotides at each end, resulting in a complex capable
of integrating the vDNA into a heterologous target. IN contains an
NLS, but similar to MA it appears to be dispensable for nuclear
import of the preintegration complex [14,15]. In the nucleus of
cells, IN targets the vDNA to sites of active transcription by
interacting with the chromosomal tethering protein p75/LEDGF
[16]. In addition to its role in integration, IN also interacts with
reverse transcriptase, is required for efficient uncoating [17], and
reverse transcription [18].
Numerous cellular proteins have been identified to interact with
MA and IN through in vitro assays. Yeast-two hybrid assays

Introduction
Efficient replication of human immunodeficiency virus type 1
(HIV-1) requires interactions with a myriad of host cell proteins.
Protein-protein interaction assays, genetic and proteomic screens
have identified hundreds of candidate proteins that potentially
interact with the virus during productive infection (reviewed in
[1]). After entry and uncoating of its viral core, there are many
critical steps during HIV-1 replication, including, but not limited
to, reverse transcription of the viral RNA (vRNA) into DNA,
nuclear import of the viral DNA (vDNA), and the integration of
the vDNA into the host cell chromosome, transcription, specific
export of unspliced viral mRNA, assembly of new virus particles,
virion egress, and maturation. All of these steps involve a complex
interplay between viral and cellular proteins [2,3].
HIV-1 matrix (MA) and integrase (IN) are components of the
gag and pol genes, respectively. Both proteins are incorporated into
virions and present in the HIV-1 reverse transcription and
preintegration complexes [4,5,6,7]. The functional role of MA in
virus assembly is well established. The N-terminal myristolation of
MA is critical for targeting the Gag and Gag-Pol polyproteins to
the plasma membrane for virus assembly [8,9]. Although MA was
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8 mM L-glutamine, 100 U/ml penicillin, and 100 mg/ml streptomycin. Hela-CD4-LTR-b-gal media was supplemented with
0.1 mg/ml G-418 and 0.1 mg/ml Hygromycin B. Viruses were
produced by transient transfection of 293T cells using polyethylenimine (PEI). Briefly, cells were seeded into 10 cm dishes at 60%
confluency one day prior to transfection. 15 mg of viral molecular
clone (pNLX) DNA and 5 mg of vesicular stomatitis virus
glycoprotein G (VSVg) expression vector pMD2.G (Addgene
Plasmid Repository) were mixed with 45 ml 1mg/ml PEI in OptiMEM (Invitrogen) minimal media. After a 10 min incubation at
room temperature the PEI/DNA solution was added to each dish.
HIV- luc viruses were produced by PEI transfection with 10 mg
pNLX-luc and 5 mg pMD2.G. MLV-luc viruses were produced by
PEI transfection with 10 mg pFB-luc, 6 mg pCG-gag-pol, and 4 mg
pMD2.G. HIV-1 biotin viruses NLXINB and NLXMAB were
produced as previously described [38]. For all virus stock
production, media was collected every 24 h for a total of 72 h,
clarified by centrifugation at 40006g for 5 min, and concentrated
using Centricon-100 concentrator units as directed by the
manufacturer (Millipore, Billerica MA). Viral stocks were quantified by RT activity using a previously described [32P]TTP
incorporation assay [38,43] and normalized amounts were used
for every experiment.

identified HEED [19], HO3 [20], and KIF4 [21] as MAinteracting proteins; and integrase interactor 1 [22], hRad18 [23],
YY1 [24], and Gemin2 [25] as IN-interacting proteins. Other IN
cofactors have been identified by their capacity to modify
integration activity in vitro, including barrier to autointegration
[26], high mobility group protein A2 (formerly known as HMG
I(Y)) [27], and the Ku70/80 heterodimer [28,29]. Recently, three
genome-wide RNAi screens have been published to identify HIV
dependency factors [30,31,32]. Each screen identified .200
candidate factors, but there was little overlap between them
[33]. Thus far, four proteins from these screens have been
validated as early HIV-1 factors: The transportin 3 nuclear import
factor [34,35] which is thought to be important for HIV-1 nuclear
import, hnRNPU, a factor identified as a HIV-1 host restriction
factor [36], and two cytoskeletal proteins DNAL1 and MAP4 [37].
In these studies HIV-1 IN and MA protein complexes were
affinity purified from 4 h infections using a previously described in
vivo biotinylation system [38]. Mass spectrometry analysis of both
IN and MA complexes identified a novel candidate cellular
protein, Leucine rich PPR-containing protein (LRPPRC, also
known as LRP130). LRPPRC was found to interact with HIV-1
RNA and DNA during early infection. Stable depletion of
LRPPRC in target cells reduced HIV-1 and MLV infection.
PCR analysis of the early steps of HIV-1 infection determined that
LRPPRC knockdown led to a reduction in nuclear import of
vDNA and reduced PIC formation. Subcellular fractionation of
the stable shLRPPRC cells revealed differential knockdown of
LRPPRC in various cellular compartments. Analysis of the
efferent steps of virus replication found that neither virus release
nor viral RNA encapsidation were affected in cells depleted of
LRPPRC. The stable knockdown of LRPPRC in 293T cells
resulted in delayed cell growth compared to cells expressing a nonspecific shRNA, suggesting a possible mechanism for the impact of
LRPPRC expression on MLV and HIV-1 infection. These data
demonstrate that LRPPRC expression is important for efficient
HIV-1 replication during the afferent stage.

Affinity purification and mass spectrometry
The previously described BAS/BirA system was used to affinity
purify protein complexes for mass spectrometry analysis [38].
Briefly, 16108 C8166-45 cells were infected by spinoculation [44]
with VSVg pseudotyped HIV-1 containing biotinylated IN
(NLXINB) or MA (NLXMAB) and incubated for 4 h at 37uC.
An uninfected cell lysate was prepared in parallel as a negative
control. Cells were washed, lysed in RIPB buffer (50 mM Tris (pH
7.5)/ 150 mM NaCl/ 1% NP-40/0.5% sodium deoxycholate/
0.1% SDS), clarified, and incubated overnight with streptavidinagarose (SA) beads. The beads were washed extensively and
captured proteins were eluted by boiling then separated on a large
format sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) system (Bio-Rad, Hercules, CA). An image of the gel
was made by staining the gel with ProtoBlue Safe (National
Diagnostics, Atlanta, GA), scanning, and enhancement using
image software. From the image a grid was constructed and each
lane was divided into 20 sections. The gel was overlaid on the grid
and each section was excised and stored at 220uC. Tryptic
digestion was performed using the ProteaseMAX surfactant
digestion protocol (Promega, Madison WI). Following extraction
the samples were purified using C-18 ZipTips (Millipore), purified
samples were concentrated to ,20 ml, and stored at 220uC until
mass spectrometry analysis. Peptide samples were analyzed by the
Nebraska Center for Mass Spectrometry. 10 ml of the extract
solution was injected onto a trapping column (300 micron 61 mm)
in line with a 75 micron 615cm C18 reversed phase LC column
(LC- Packings). Peptides were eluted from the column using a
water +0.1% formic acid (A)/95% acetonitrile: 5% water +0.1%
formic acid (B) gradient with a flow rate of 270 nl/min. The
gradient was developed with the following time profile: 0 min 5%
B, 5 min 5% B, 35 min 35% B, 40 min 45% B, 42 min 60% B,
45 min 90% B, 48 min 90% B, 50 min 5% B. The eluting
peptides were analyzed using a Q-TOF Ultima tandem mass
spectrometer (Micromass/Waters) with electrospray ionization.
Analyses were performed using data-dependant acquisition (DDA)
with the following parameters: 1sec. survey scan (380–1900
daltons) followed by up to three 2.4 sec MS/MS acquisitions (60
to 1900 daltons). The instrument was operated at a mass
resolution of 8,000. The instrument was calibrated using the

Materials and Methods
Plasmids
pNLX [39], pES [40], and pSIVmne [41] have all been
previously described. The shRNA plasmids targeting LRPPRC
(shLRPPRC 02, 03, 04), the non-specific (NS) shRNA plasmid,
and pFlag-LRPPRC were obtained from Origene Technologies
(Rockville, MD). pNLX-luc, pFB-luc and pCG-gagpol were kindly
provided by Alan Engelman [42]. The plasmid standard for
integration assays, pTZ19R-LTR, was constructed by inserting the
HIV-1 LTR into pTZ19R (Fermentas, Glen Burnie, MD USA).
The HIV-1 LTR was amplified by a standard PCR with a 59
BamH1 and 39 Pst1 linkers. The 59 primer was NL1-BH1 (59GCGGGATCCTGGAAGGGCTAATTTGGTCC-39; BamH1
site underlined) and 39 primer was cNL702Pst1 (59GCGCTGCAGGCCGAGTCCTGCGTCGAGAG-39; Pst1 site
underlined). The PCR product was gel purified and digested with
BamH1/Pst1. The digested DNA was ligated to BamH1/Pst1
digested pTZ19R. The resulting plasmid was verified by DNA
sequencing (Creighton University Molecular Biology Research
Core Facility).

Cell culture and virus preparation
293T and Hela-CD4-LTR- b-gal cells (NIH AIDS Research
and Reference Reagent Program, Germantown, MD) were
maintained in Dulbecco’s modified eagle medium (DMEM)
supplemented with 10% fetal clone 3 (Hyclone, Logan, UT),
PLoS ONE | www.plosone.org
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clarified by centrifugation at 20,0006 g for 5 min. 25 ml of the cell
lysate was loaded into a white 96-well plate and mixed with 50 ml
One-glo luciferase reagent (Promega, Madison, WI). Luciferase
activity was measured using a Spectramax L (Molecular Devices,
Sunnyvale, CA). Uninfected cell lysate and M-PER solution only
were used as negative controls for each assay. Data shown
represents at least three independent experiments. For single-cycle
infectivity assays, 0.256106 HeLa T4 b-gal cells were seeded into a
6-well plate and transfected the next day with 2 mg of plasmids
shLRP -02, -03, -04, or a plasmid expressing a non-specific
shRNA (NS) using TransIT-LT1 (Mirus Bio). 24 h post-transfection, each well of cells was trypsinized and seeded into 4 wells of a
12-well plate. 48 h post transfection, the cells in three wells were
infected and assays carried out as previously described [38]. The
cells in the fourth well were harvested, washed with PBS, lysed
with 100 ml of M-PER solution (Pierce Biotechnology, Rockford,
IL), and the level of LRPPRC knock-down monitored by Western
blot as described above. The results presented represent data from
nine independent infections.

fragment ion masses of doubly protonated Glu-fibrinopeptide. The
peak lists of MS/MS data were generated using Distiller (Matrix
Science, London, UK) using charge state recognition and deisotoping with the other default parameters for Q-TOF data. Data
base searches of the acquired MS/MS spectra were performed
using Mascot (Matrix Science, v1.9.0, London, UK). The MSDB
database (a comprehensive, non-identical protein sequence database maintained by the Proteomics Department at the Hammersmith Campus of Imperial College London which combines
entries from TREMPL, SWISSPROT and GENBANK) (Release
02272005, 1,942,918 sequence entries) was used and the
taxonomy filter was set to ‘‘human’’. Search parameters used
were: no restrictions on protein molecular weight or pI, enzymatic
specificity was set to trypsin, and methionine oxidation was
allowed as a variable peptide modification. Mass accuracy settings
were 0.15 daltons for peptide mass and 0.12 daltons for fragment
ion masses. Significant protein hits that matched more than one
peptide with p,0.05 were identified. In the same gel fraction,
protein hits matching only redundant peptides with other protein
hits of higher scores were removed. Data was compiled from a
total of 6 replicates and proteins unique to the infected samples
were identified by comparison to the uninfected control.

Reverse transcription and nuclear import quantification
293T shLRPPRC cells were seeded in 10 cm dishes to achieve
50–60% confluence the following day. NLX-Luc stocks were
treated with 2 U/ml Turbo DNase (Ambion, Austin TX) for 1 h
at 37uC. Cells were transduced with normalized amounts of NLXLuc vector and incubated at 37uC for 24 h. Media was removed
and extra-chromosomal DNA was isolated using the modified
HIRT protocol [38,45]. HIV-1 and cellular DNA was amplified
using iQ SYBR Green Super Mix on an iQ5 multicolor real-time
PCR detection system (Bio-Rad) using 250 nM of each primer.
Late reverse transcription (LRT) viral DNA was quantified using
gag-specific primers NL919 (59-TTCGCAGTTAATCCTGGACTT-39) and NL1054 (59-GCACACAATAGAGGACTGCTATTGTA). LRT was normalized to detection of mitochondrial
DNA using primers MitoFor (59-ACCCACTCCCTCTTAGCCAATATT-39) and MitoRev (59-GTAGGGCTAGGCCCACCG-39). 2-LTR circles were quantified using primers
NL500
(59-AACTAGGGAACCCACTGCTTAAG-39)
and
NL9126 (59-TCCACAGATCAAGGATATCTTGTC-39) and
normalized to the level of LRT viral DNA. Heat inactivated virus
(30 min at 65uC) was used as a negative control for each
experiment.

293T shLRPPRC cells
56105 293T cells were seeded into a single well of a six-well
dish, grown overnight, then transfected with 2 mg shLRP 02, 03,
04, or a NS using TransIT-LT1 as directed by the manufacturer
(Mirus Bio, Madison WI). 48 h post-transfection, the cells were
seeded into four 10 cm dishes and propagated in complete DMEM
media containing 1 mg/ml Puromycin (Calbiochem, La Jolla, CA)
until colonies were visible. Single colonies were isolated using
cloning cylinders and seeded into 96-well plates by trypsinization.
Clonal cell lines were expanded and LRPPRC expression was
examined by SDS-PAGE and Western blot using an antiLRPPRC antibody (H-300; Santa Cruz Biotechnology, Santa
Cruz, CA). The primary antibody was incubated overnight at 4uC,
followed by HRP conjugated anti-rabbit IgG secondary antibody
(GE Healthcare, Piscataway, NJ) and visualization by chemiluminescence (Pierce Biotechnology, Rockford, IL). Western blot
images were acquired using an Image Station 4000R (Carestream
Molecular Imaging, New Haven, CT) and, if necessary to improve
quality, sharpened and adjusted for brightness/contrast using
Adobe Photoshop. LRPPRC knockdown was quantified by
relative optical intensity analysis using Kodak image software.
The level of LRPPRC knockdown for each cell clone was
calculated by comparing the level of LRPPRC expression to the
level of actin, which was detected using anti-actin primary
antibody (I-19; Santa Cruz Biotechnology) followed by horseradish
peroxidase (HRP) conjugated anti-rabbit IgG secondary antibody.
Cell lines used for assays were designated 293T -NS, -2.7, -3.6,
and -4.1. Cell fractionations were carried out with the Qproteome
kit according to the manufacturer’s protocol (Qiagen, Valencia,
CA). Western blot of fractionations were carried out as described
above. The eIF4E protein was detected using antibody FL-217
(Santa Cruz), SLIRP was detected using antibody G-21(Santa
Cruz), and c-Myc was detected using antibody G-4 (Santa Cruz).
Detection of GAPDH was used as a loading control.

Integration assays
Integration assays were essentially performed as described [38].
Briefly, 26107 293T cells were infected with concentrated, VSVgpseudotyped HIV-1 for 6 h. Cells were lysed by hypotonic
swelling/dounce homogenization, the nuclei and cell debris
removed by centrifugation, and the lysates snap frozen in liquid
nitrogen and stored at 220uC. PIC-containing lysates were
thawed on ice and treated with 20 mg/ml RNase A (Qiagen) for
10 min at room temperature prior to integration reactions.
Reactions were performed in 20 mM HEPES (pH 7.4), 150 mM
KCl, 1 mM MgCl2, 4% glycerol, 5 mM DTT. 250 ml of lysate or
concentrated fraction was assayed in the presence or absence of
3 ng/ml pTZ19R target DNA (Fermentas). The reactions were
incubated on ice for 5 min then transferred to 37uC for 45 min.
Assays were stopped by the addition of EDTA to 8 mM. Each
sample was deproteinated by the addition of SDS and Proteinase
K (0.5% and 0.5 mg/ml final concentration, respectively) and
incubation at 56uC for 1.5 h. DNA was extracted once with an
equal volume of phenol and twice with equal volumes of
phenol:chloroform:IAA. The DNA was precipitated with 0.3 M
sodium acetate, 1 ml GenElute LPA (Sigma Aldrich, St. Louis,

Viral infectivity assays
For the luciferase assays, 46104 293T shLRPPRC cells (-2.7, 3.6, -4.1, and -NS) were seeded in triplicate wells of a 24-well
plate. The following day each well was inoculated with 100 ml of
HIV-luc or MLV-luc and incubated for 48 h at 37uC. Cells were
lysed in 100 ml M-PER solution (Pierce Biotechnology) and
PLoS ONE | www.plosone.org
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MO USA), and 2.5 volumes 100% ethanol overnight at 220uC.
Samples were centrifuged at 21,0006 g for 15 min, washed with
150 ml 70% ethanol, re-centrifuged, air-dried 5–10 min, resuspended in 20 ml Tris-EDTA, and stored at 220uC. The nested
PCR strategy to measure integration activity was performed as
described previously [38] except that 10-fold dilutions of pTZ19RLTR were used as a real-time PCR standard for each real-time
PCR.

St. Louis, MO USA), and 2.5 volumes 100% ethanol overnight at
220uC. RNA and DNA were purified by centrifugation for
10 min at 13,0006 g, washed with 70% ethanol, and eluted in
50 ml Tris-EDTA. Prior to real-time PCR, the DNA was removed
from all RNA samples using turbo DNA-free DNase as directed by
the manufacturer (Ambion). Viral RNA and DNA were detected
using primers NL919 and cNL1054.

Results
Cell cycle and proliferation assays

Identification of LRPPRC

293T shLRPPRC cell lines were seeded at 16105 cells/10 cm
plate in triplicate. At the times indicated the cells were harvested,
diluted 1/500 in isotonic saline, and counted using a Z1 Coulter
particle counter (Beckman Coulter, Fullerton, CA). Two independent counts were taken for each replicate per time point. For cell
cycle analysis, 16106 293T shLRPPRC cells were harvested by
centrifugation, resuspended in Vindelov’s reagent (10mM Tris (pH
7.6), 10 mg/ml RNase A, 75 mM propidium Iodide, and 0.1%
Igepal CA-630) and incubated overnight at 4uC. Cells were
analyzed at the Creighton University flow cytometry core using a
FACSAria flow cytometer (BD Biosciences, San Jose, CA) and
Flowjo software (Treestar Inc., Ashland, OR). MTT assays were
performed on the shLRPPRC cells using the CellTiter 96 nonradioactive cell proliferation assay according to the manufacturer’s
specifications (Promega). A preliminary assay was performed to
determine the optimum incubation time. The absorbance values
were obtained using a Versamax plate reader (Molecular Devices).

To investigate the proteome of HIV-1 protein complexes, we
utilized a previously described biotinylation system to affinity
capture HIV-1 integrase (IN) and matrix (MA) protein complexes
in vivo [38]. This system is based on the ability of the E. coli biotin
ligase BirA to recognize and biotinylate the central lysine residue of
a 20 amino acid biotin acceptor sequence (BAS). Tagged proteins
can be efficiently captured with streptavidin-agarose. Two clones
were constructed previously with the BAS inserted into the Cterminus of the IN and MA proteins (MABAS and INBAS,
respectively; [38]). Both clones efficiently produced biotinylated
virus in the presence BirA. The MABAS virus was able to infect and
replicate in SupT1 T cells comparable to wild-type virus, while the
INBAS virus was replication defective due to a loss of integration
activity.
Although defective for integration, the INBAS virus was
competent for reverse transcription (data not shown). Therefore,
we used both clones to capture early viral protein complexes at 4
hours post infection (hpi). High titer stocks of VSVg-pseudotyped
viruses containing biotinylated IN or MA were produced by
transient transfection of a 293T cell line stably expressing BirA.
C8166-45 cells were infected by spinoculation and at 4 hpi the
cells were lysed and protein complexes affinity purified with
streptavidin-sepharose. For each experiment an uninfected sample
was prepared in parallel as a background control. The captured
protein complexes were separated by 1-D SDS-PAGE, block
excised, and analyzed by liquid chromatography-tandem mass
spectrometry (LC-MS/MS). An example of a Sypro stained
proteomic gel is shown in Figure S1. Due to a high level of
background binding to streptavidin beads, IN- and MA-associated
proteins were identified by comparing the MS data from the
affinity purified samples to the uninfected control samples. The top
candidate cellular proteins unique to the infected samples (ranked
by Mascot score and number of peptide hits) are shown in Table 1
and a list of all unique proteins identified is provided in Table S1.
Four putative HIV-1 factors: eEF1A1 (EF-tu) [46], Cyclophilin A
[47,48,49], Cyclophilin B [50], Heat shock protein 90 AA1 [51],
and Heat shock protein 70 protein 9 [52,53] were well represented
in the infected samples. Although the heat shock proteins have
been previously identified as an HIV-1 factor, these proteins can
also non-specifically associate with sepharose-beads which are
commonly used in affinity purification [54]. As, expected, there
were also a large number of HIV-1 proteins identified only in the
infected samples (Table S2). Both IN (Pol) and MA (Gag) were
identified by MS and each was present in larger quantities within
the corresponding pull-down as indicated by total peptide hits.
To validate the presence of the proteins identified by MS we
performed Western blots on the affinity purified (AP) protein
complexes (Fig. 1A). The capture of biotinylated IN and MA was
confirmed using a streptavidin-HRP antibody (Fig. 1A, top panel).
The protein identified with both the highest Mascot score and
number of total peptide hits, Leucine rich PPR-motif containing
protein (LRPPRC, also known as LRP130), was detected
prominently in both the IN and MA AP samples (Fig. 1A, second

Virus release assay and viral RNA quantification
shLRPPRC 293T cells were seeded in 6-well plates at 50%
confluency and transfected with pNLX using PEI as described
above. Supernatants were collected at 24 h post-transfection for
viral p24 ELISA and viral RNA quantification. p24 ELISAs were
performed per the manufacturer’s specifications (Advance Bioscience Laboratories Inc, Kensington, MD). viral RNA was isolated
from the supernatant using the QIAamp Viral RNA isolation kit
(Qiagen) and the relative levels quantified using iScript one-step
RT-PCR kit with SYBR green (Bio-Rad, Hercules, CA) using
250 nM of each HIV-1 gag-specific primers NL919 and NL1054.
PCR was performed on an iQ5 multicolor real-time PCR
detection system (Bio-Rad). A dilution series of pNLX DNA
plasmid was measured to generate a standard curve for the realtime RT-PCR reaction. Viral RNA encapsidation was calculated
as ratio of fg viral RNA/ ng p24.

Immunoprecipitation RT-PCR assays
For IP-RT-PCR assays of infected cells, 16106 cells were
infected by spinoculation [44] with NLX + VSVg virus in the
presence of 8ug/mL polybrene. After 4 h the cells were harvested,
washed in PBS, and resuspended in 500 ml of IP lysis buffer
(Pierce) and pre-cleared with 50 ml protein G agarose beads preequilibrated in lysis buffer for 1 h at 4uC. The beads were removed
and the samples incubated with antibody at 1/100 dilution
overnight at 4uC. The following day 50 ml of protein G agarose
beads were added and incubated for an additional 4 h at 4uC. The
immune complexes were washed three times for 15 min in lysis
buffer and digested for 30 min at 37uC with 100 mg proteinase K
in 200 ml of 50 mM Tris (pH 8.0)/1% SDS/10 mM EDTA. Viral
RNA was extracted with one round each of phenol-chloroformisoamyl alcohol (25:24:1), acid phenol-chloroform extraction, and
precipitated by isopropanol with 1ml LPA. DNA was extracted
once with an equal volume of phenol and twice with equal
volumes of phenol:chloroform:IAA. The DNA was precipitated
with 0.3 M sodium acetate, 1 ml GenElute LPA (Sigma Aldrich,
PLoS ONE | www.plosone.org
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Table 1. Top candidate proteins identified in MS/MS analysis.

Gene ID

Gene name

Total (IN/MA)
replicate hits

Total peptide
hits

Total MASCOT
score

Mean MASCOT
score/replicate

Notes

1915

eEF1A1/EF-tu

20 (16/4)

51

2444

122.2

HIV-factor

46

10128

LRPPRC

10 (6/4)

52

2649

264.9

RNA binding

5478

Cyclophilin A

3 (2/1)

7

427

142.3

HIV-1 factor

47–49

5479

Cyclophilin B

3 (1/2)

3

237

79.0

HIV-1 factor

50

3313

HSP70 protein 9

10 (8/4)

81

4903

408.6

HIV-1 factor

52,53

10131
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panel); however, over-exposure produced a small band in the
uninfected sample (data not shown). Additionally, we validated the
presence of two other unique proteins in the IN and MA AP
samples, CRKL and eEF1A1 (Fig. 1A, third and fourth panels).
Finally, as a control we assayed for a protein ubiquitously detected
in our MS analysis, MCCA, that binds endogenous biotin for
metabolic processes. As expected, MCCA was detected in all
samples (Fig. 1A, bottom panel). Overall these data confirm
several of the MS hits and demonstrate the efficacy of the
approach.
LRPPRC was discovered originally as a highly over-expressed
transcript in human hepatocellular carcinoma (HepG2) cells [55],
and has subsequently been described to have several diverse
cellular functions. It is a member of a family of proteins that
contain numerous copies of a unique structural motif called the
pentatricopeptide repeat (PPR) [56]. It was characterized as a
RNA/DNA binding protein found in the cytoplasm, mitochondria, and the nucleus of cells [57,58,59]. In addition, LRPPRC
was identified as a component of the peroxisome proliferatoractivated receptor coactivator 1-a (PGC-1 a) complex, which
regulates energy metabolism in many tissues [60]. LRPPRC is also
implicated in the human disease known as Leigh syndrome, a
French-Canadian type cytochrome c oxidase deficiency [61,62],
which suggest an important role in mitochondrial metabolism.
Recent work demonstrated that LRPPRC is a binding partner of
eukaryotic initiation factor 4E (eIF4E), a cap-binding protein that
also regulates the export of mRNAs related to cell cycle, including
c-myc, Pim-1, and Cyclin D1 [63]. Additionally, LRPPRC was
identified as a strong binding partner of the SRA stem-loop
interacting RNA-binding protein (SLIRP) [64]. Interestingly,
knockdown of LRPPRC led to a dramatic decrease in SLIRP
levels and conversely knockdown of SLIRP led to a decrease in
LRPPRC levels suggesting interdependent functions [64,65].
To confirm the presence of LRPPRC in RTCs/PICs at 4 hpi
and investigate its mechanism of association with HIV-1 NPCs, we
performed co-immunoprecipitation (IP) assays with IN and MA,
IP-RT-PCR assays for RNA interaction, and IP-PCR assays for
DNA binding. 293T cells were transfected with Flag-LRPPRC
and 24 hours later infected with VSVg-pseudotyped HIV-1. Four
hours post-infection the cells were lysed and immunoprecipitated
with isotype control, anti-Flag, or anti-integrase antibodies.
LRPPRC was not found to directly co-IP with either IN or MA
in replicate assays (data not shown). To determine whether
LRPPRC interacted with viral RNA or DNA, immunoprecipitates
were digested with proteinase K, RNA or DNA extracted, and
viral copies quantified by real-time RT-PCR or PCR using gagPLoS ONE | www.plosone.org

specific primers. The mouse isotype control antibody was used to
measure background in each experiment and the average
background binding was subtracted from each IP sample after
qPCR. Infection with heat-inactivated virus was used as a negative
control and anti-IN antibody was used as a positive control for
these studies [66]. Immunoprecipitation of Flag-LRPPRC specifically captured HIV-1 viral RNA (Fig. 1A) and viral DNA (Fig. 1B)
in early HIV-1 infection. This suggested that LRPPRC interacted
with RTCs and PICs during early infection via an association with
viral nucleic acids.

Cell compartment specific depletion of LRPPRC in 293T
cells
To investigate the requirement of LRPPRC for HIV-1
infection, we constructed 293T cell lines stably depleted of
LRPPRC by short hairpin RNA (shRNA) interference. The cells
were transfected with three independent LRPPRC-specific shRNA
expression constructs and selected by incubation with puromycin.
Clonal cell lines were isolated by limiting dilution and screened for
LRPPRC knock-down by Western blot analysis (data not shown).
A cell line stably transfected with a nonspecific (NS) shRNA
expression plasmid was made in parallel for control studies
(293T.NS). Several cell clones were identified for each shRNA
with substantial reductions in LRPPRC expression compared to
the NS cells or parental 293T cell line. The cell lines that exhibited
the lowest levels of LRPPRC expression for each shRNA
compared to the NS stable cell line were designated 2.7, 3.6,
and 4.1 and used in further experiments. Densitometry analysis of
Western blots using actin as a normalization control indicated that
compared to the NS control cell line, the 2.7 cells had an
approximate 64% reduction in LRPPRC expression and a 99%,
and 98% reduction of LRPPRC in cell lines 3.6 and 4.1 cell lines
respectively (Fig. 2A).
LRPPRC is a multifunctional protein with putative roles in both
mitochondrial and nuclear RNA metabolism. To characterize the
knockdown of LRPPRC in each cell line we assessed LRPPRC
expression in subcellular fractions. Cells were divided into
cytoplasmic, membrane/organelle, nuclear, and insoluble/cytoskeletal fractions using detergent fractionation and examined by
Western blot. The quality of fractionation for each sample was
monitored in each experiment by the detection of GAPDH
(cytoplasmic) and topoisomerase IIa (nuclear; Fig. 2B, bottom
panels). No LRPPRC was detected in the cytoplasmic/soluble
fraction of cells. The majority of LRPPRC protein was detected in
the membrane/organelle fraction consistent with its association
with mitochondria. There was only a small, if any decrease in
5

July 2012 | Volume 7 | Issue 7 | e40537

LRPPRC Expression Is Required for HIV-1 Infection

Figure 1. LRPPRC is present in affinity purified samples and associates with HIV-1 RNA and DNA complexes during early infection.
(A) Western Blot analysis of affinity purified samples. C8166 cells were infected with VSVg pseudotyped NLXINB or NLXMAB virus. An uninfected
control was performed in parallel. Cells were lysed with IP buffer and protein complexes were affinity purified using SA-agarose. SA-agarose bound
protein complexes were separated by SDS-PAGE and subjected to Western Blot with streptavidin-HRP and the indicated antibodies. (B)
Immunoprecipitation RT-PCR in 4h infected cells. 293T cells were transfected with Flag-LRPPRC and infected with NLX. The cells were lysed,
immunoprecipitated with the indicated antibodies, viral RNA isolated and quantified by real-time RT-PCR. The background level of viral RNA isolated
from an isotype control immunoprecipitation was subtracted from each sample. (C) Immunoprecipitation PCR in 4h infected cells. Experiments were
performed as in (B) except viral DNA was isolated and detected by real-time PCR. Data shown in both panels is representative of 3 replicates and error
bars show SEM.
doi:10.1371/journal.pone.0040537.g001

proliferation. It was previously reported that knockdown of
LRPPRC reduces nuclear protein levels of eIF4E which reduced
the expression of several factors associated with cell cycle
progression. To determine if LRPPRC knockdown altered the
expression of cell cycle factors we examined their expression in the
subcellular fractions of the shLRPPRC cells (Fig. 2B). eIF4E was
expressed in all cell compartments in the NS cells. However there
was a decrease in nuclear-associated eIF4E in the 3.6 and 4.1 cell
lines (Fig. 2B, second column), which is in line with previous results
indicating that knockdown of LRPPRC inhibits eIF4E translocation into the nucleus [63]. Interestingly, the 2.7 cells which have
normal levels of nuclear-associated LRPPRC also exhibited
normal localization of eIF4E in the nuclear fraction. Consistent
with previous results, SLIRP was detected in only the mitochondrial containing fraction in NS cells, and protein levels were

protein expression in this fraction of the 2.7 cell line (Fig. 2B first
column), while the 3.6 and 4.1 cell lines demonstrated a greater
decrease. Both the 3.6 and 4.1 cell lines had a decrease in nuclearassociated LRPPRC, but the 2.7 cell line surprisingly showed no
depletion in this compartment. Compared to the NS cell line all
three of the shLRPPRC cell lines exhibited a strong reduction in
LRPPRC expression in the cytoskeletal/insoluble fraction. Combined, these data suggest that the incomplete knockdown of
LRPPRC in the 2.7 cell line was due to a lack of substantial
knockdown of LRPPRC expression in the mitochondria and
nuclei of those cells.
Next the expression of several cellular factors known to interact
with LRPPRC was investigated. LRPPRC interacts with eukaryotic initiation factor 4E (eIF4E), an RNA regulatory protein that
regulates the expression of several proteins involved in cellular
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Figure 2. Stable knockdown of LRPPRC alters the subcellular localization of several proteins. (A) Level of LRPPRC knockdown in 293T
cells stably transfected with the indicated LRPPRC-specific shRNAs. Knockdown was determined by comparing LRPPRC expression (top panel) to actin
expression (bottom panel). WT shows the parental 293T cell line. (B) Subcellular fractionation of the shLRPPRC cell lines. The indicated cell lines were
fractionated into cytoplasmic, membrane/organelle, nuclear, and insoluble/cytoskeletal fractions and LRPPRC, eIF4E, SLIRP, and c-Myc expression
were determined by Western blot. GAPDH and Topoisomerase IIa (lower panel) were detected to ensure proper cell fractionation. Data is
representative of 3 independent experiments.
doi:10.1371/journal.pone.0040537.g002

with VSVg-pseudotyped HIV-Luc. Virus transduction was measured by luciferase expression at 48 hours post transduction
(Fig. 3A). Compared to the 293T.NS cells, an approximately 75%
decrease in HIV-Luc transduction was observed for all three of the
shLRPPRC cell lines, indicating that LRPPRC expression was
critical for efficient infection. To determine whether the effect of
LRPPRC knockdown was specific to HIV-1, the efficiency of
transduction of a murine leukemia virus vector (MLV-Luc) into
each cell line was measured (Fig. 3B). Interestingly, the 2.7 cell
line, which has wild-type levels of nuclear LRPPRC and normal
expression of eIF4E and SLIRP, facilitated MLV transduction at a
comparable level to the NS cells. In contrast, a 50% decrease in
MLV transduction was observed in the 3.6 and 4.1 cell lines,
which have depleted nuclear and cytoskeletal/insoluble LRPPRC
and reduced SLIRP and nuclear eIF4E. These data indicated that
there were possibly two mechanisms through which LRPPRC
depletion affected HIV-1 infectivity, and that nuclear LRPPRC
was required for retroviral infection.

reduced in the 2.7 and 3.6 cell lines, and it was absent in the 4.1
cells (Fig. 2B, third column). Cellular c-Myc was also detected in
NS cells in the membrane/organelle fraction with lower levels
detected in the cytoskeletal/insoluble fraction (Fig. 2B, fourth
column). The levels were not altered in the 2.7 cell line, but were
reduced in the membrane/organelle fraction of 3.6 cells and
absent in the 4.1 cell line. Combined, these data demonstrate that
LRPPRC knockdown altered the expression of other cell cycle
factors. Moreover, the 2.7 cell line had a different knockdown
profile compared to 3.6 and 4.1 cell lines. The 2.7 cell line had a
milder knockdown of LRPPRC compared to the other two cell
lines and no change in the levels of eIF4E and c-Myc compared to
the NS cells.

LRPPRC knockdown decreases HIV-1 infection
To test if LRPPRC was necessary for HIV-1 infection we
measured the transduction of a HIV-1 virus engineered to express
luciferase (HIV-Luc) into the LRPPRC-depleted cell lines. In each
experiment the cell lines were seeded in triplicate and inoculated
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Figure 3. Knockdown of LRPPRC impairs HIV-1 infection. HIV-1 (A) and MLV (B) infection of cells stably depleted of LRPPRC. The indicated
shLRPPRC cell lines were transduced with normalized levels of VSVg-pseudotyped HIV-1 and MLV luciferase viruses for 48 h. Data is normalized to the
NS cells. ** Denotes p,0.001 as determined by two-tailed t-test, the error bars denote standard deviation, and the data is representative of at least
three independent experiments. (C) Single cycle infectivity assays with LRPPRC-depleted cells. LRPPRC was transiently depleted in Hela-CD4-LTR-b-gal
indicator cells with three LRPPRC-specific shRNAs (indicated on x-axis) 24 hrs prior to infection with HIV-1. Infectivity was measured by counting blue
nuclei (indicated on y-axis). Example of transient knockdown of LRPPRC in Hela-CD4-LTR-b-gal cells is shown below the graph by anti-LRPPRC and
anti-actin Western blots. Data is the average of 9 independent infections and ** denotes p,0.001 as determined by two-tailed t-test. Error bars
denote SEM.
doi:10.1371/journal.pone.0040537.g003

To corroborate the requirement of LRPPRC expression for
HIV-1 infection, the effect of knockdown was investigated in a cell
line that facilitates CD4-dependent HIV-1 entry. Single-round
infectivity assays were performed using HIV-1 indicator HeLaCD4-LTR-b-gal cells transiently depleted of LRPPRC (Fig. 3C).
Similar to the stable cells, shRNAs 03 and 04 suppressed LRPPRC
expression greater than 02 in replicate experiments. Despite this,
all three LRPPRC-specific shRNA or the nonspecific shRNA were
individually transfected into HeLa-CD4-LTR-b-gal cells 24 h
prior to inoculation with normalized levels of HIV-1 overnight.
Similar to the transduction experiments in the shLRPPRC cell
lines, all three of the shRNAs to LRPPRC significantly decreased
HIV-1 infectivity by at least three-fold compared to the cells
transfected with the NS control plasmid. These data confirmed
that LRPPRC expression was required for efficient HIV-1
infection via its natural route of entry.

qPCR analysis. To control for the extraction of DNA in each
experiment the LRT product levels were normalized to the level of
mitochondrial DNA in each sample. There was no difference in
LRT viral DNA accumulation between any shLRPPRC cells
compared to the NS cells (Fig. 4A), indicating that the depletion of
LRPPRC did not affect the steps of virus replication through
reverse transcription. Next, the level of viral DNA nuclear import
was quantified in each cell line by measuring the accumulation of
2-LTR circles (Fig. 4B). In these experiments, the levels of 2-LTR
circles were normalized to the level of LRT product in each
sample to control for infection levels. There was no significant
decrease of 2-LTR circle DNA in infected 2.7 cells compared to
the NS shRNA-containing cells, indicating there was no defect in
nuclear import in those cells. In contrast, an approximately 2-fold
decrease of 2-LTR circle DNA was recovered from both the 3.6
and 4.1 cell lines, suggesting a defect in nuclear import in those cell
lines.
To assess preintegration complex (PIC) formation in the
LRPPRC depleted cells, each shLRPPRC cell line was transduced
with equivalent amounts of NLX +VSVg and PICs harvested at 6
hpi. Lysates were normalized for viral DNA content and the level
of specific integration activity measured by an in vitro integration
assay. All shLRPPRC cell lines produced lower levels of PIC
activity compared to NS control cells (Fig. 4C). The level of PIC
activity in the 2.7 and 3.6 cell lines was approximately 2-fold less
than the NS cells, and there was a .4-fold reduction in PIC
activity recovered from the 4.1 cell line. These results further
demonstrated that LRPPRC depletion affected the early events of
HIV-1 infection.

Loss of LRPPRC reduces HIV-1 PIC formation and nuclear
import
To identify which aspect of infection was impaired in the
LRPPRC-depleted cells, we assessed reverse transcription, nuclear
import, and PIC formation in the LRPPRC depleted cell lines.
Late reverse transcription (LRT) and 2-LTR circle viral DNA
products were measured by quantitative real-time PCR to analyze
reverse transcription and nuclear import, respectively. PIC
formation was quantified by in vitro integration assays. To
measure viral DNA species each shLRPPRC cell line was
transduced with equivalent amounts of DNase treated HIV-Luc
virus and extra-chromosomal DNA was isolated at 24 hpi for
PLoS ONE | www.plosone.org
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NS cells and data combined from three independent experiments. The
error bars denote SEM and ** denotes p,0.01 calculated by two-tailed
t-test.
doi:10.1371/journal.pone.0040537.g004

LRPPRC is not required for virus assembly and release
Thus far, the data indicated that LRPPRC was important for
the early steps of HIV-1 replication. However, LRPPRC plays a
role transcriptional regulation [58] and the nuclear export of
mRNA [63]. To investigate whether the expression of LRPPRC
affected the efferent stages of virus replication, we measured virus
release and RNA encapsidation from shLRPPRC cell lines
transfected with HIV-1 NLX molecular clone. Supernatants were
collected at 48 h post transfection and virus production measured
by p24 ELISA. In multiple experiments all three of the LRPPRC
depleted cell lines produced levels of virus comparable to the NS
cells (Fig. 5A), indicating there was no defect in virus expression,
assembly, or release. To evaluate if LRPPRC depletion affected
viral RNA encapsidation, the amount of viral RNA in supernatants was quantified by real-time RT-PCR, and the amount per ng
p24 calculated (Fig. 5B). No substantial change in the levels of
RNA encapsidation was observed between the NS and the
LRPPRC knockdown cell lines. Moreover, the infectivity of viruses
produced from shLRPPRC cells was not reduced compared to
virus produced from the NS cells (data not shown) and we did not
detect LRPPRC in purified virions (data not shown). Combined,
this data indicated that LRPPRC was not critical for the efferent
steps of virus replication.

Growth characteristics and expression profiles of the
shLRPPRC cell lines
LRPPRC reportedly modulates cellular proliferation by regulating the expression of factors necessary for the progression of the
cell cycle and proper mitochondrial function. Moreover, HIV-1
infection is known to modulate metabolic pathways during
productive replication [67,68]. Combined these findings suggested
a possible mechanism for the observed effect of LRPPRC
depletion on HIV-1 infectivity. To determine if the LRPPRCdepleted cells had an altered proliferation phenotype, we
measured the growth rate of each shLRPPRC cell line. Cell lines
were seeded at low confluency and growth rate monitored by
counting cells at 8 or 16 h intervals for 96 h. Two of the three
LRPPRC depleted cell lines, 3.6 and 4.1, displayed a $2-fold
reduction in the proliferation rate compared to the 293T.NS
control cells (Fig. 6A). Indeed, the growth curves correlated with
the overall level of LRPPRC knockdown and the expression of
nuclear LRPPRC (Fig. 2). The partially depleted 2.7 cell line that
retained nuclear LRPPRC grew slightly slower than the NS cells,
whereas both the 3.6 and 4.1 cells grew at a rate approximately
half that of the NS cells.
Since LRPPRC is implicated in the regulation of mitochondrial
metabolism the mitochondrial health of each cell line was
evaluated. We first checked general mitochondrial enzymatic
activity by MTT assay. Both the 2.7 and 3.6 cell lines produced
comparable levels of MTT as the NS cells (Fig. 6B). There was a
slight reduction in MTT activity in the 4.1 cell line, but it was #2fold compared to the NS cell line. Second, we measured the
mitochondrial membrane integrity as a marker for apoptosis in
each cell line by JC-1 dye staining assay; but there were no
differences among the cell lines (data not shown). These data
suggested that there was no substantial mitochondrial defect in the
LRPPRC-depleted cells.
Finally, the cell cycle profiles of the cell lines were determined to
detect any defects in cell cycle progression for each cell line. Cells

Figure 4. LRPPRC depletion reduces HIV-1 nuclear import and
PIC formation. (A) LRT product synthesis in LRPPRC depleted cells.
HIV-1 LRT products were measured at 24 hpi by real-time PCR and
normalized to the level of mitochondrial DNA in each sample. (B) 2-LTR
circle accumulation in LRPPRC cells. 2-LTR circles were quantified by
real-time PCR and normalized to the level of late RT product in each
sample. Data in panels (A) and (B) are from 3 independent experiments
and the error bars denote SEM. ** denotes p,0.01 calculated by twotailed t-test. (C) PIC activity in shLRPPRC infected cells. In vitro
integration activity +/2 target DNA was determined for each cytosolic
lysate at 6 hpi. Data was normalized to the activity recovered from the
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Figure 5. Knockdown of LRPPRC does not affect viral RNA
encapsidation or virus release. (A) Viral release from shLRPPRC cells
transiently transfected with pNLX was measured by p24 antigen ELISA.
(B) RNA encapsidation in virus produced from shLRPPRC cells. RNA was
isolated from supernatants and quantified by real-time RT-PCR.
Encapsidation was calculated as a ratio of viral RNA (fg) to p24 (ng).
Each sample was measured in triplicate and error bars denote SD. Data
is representative of 3 independent experiments.
doi:10.1371/journal.pone.0040537.g005

Figure 6. Characterization of shLRPPRC cells. (A) Growth of
shLRPPRC cells. NS and shLRPPRC cells were seeded in triplicate and
counted with a cell counter every 8 and 24 h for a total of 96 h. Data
shown is representative of two experiments and error bars denote SD.
(B) MTT assay of NS and shLRPPRC cells. Cells were seeded in a 96-well
plate and were incubated for 24 h at 37uC prior to addition of the dye
reagent. Cells were incubated an additional 2 h and absorbance
measured. Assay was performed in triplicate and data is representative
of three independent experiments. Error bars denote SD. (C) Cell cycle
profiles of NS and shLRPPRC cells. Proliferating cells were stained with
Vindelov’s reagent and analyzed by flow cytometry to determine the
percent of cells in each phase of the cell cycle. Data shown is
representative of three independent experiments and the error bars
denote SD.
doi:10.1371/journal.pone.0040537.g006

were stained with Vindelov’s reagent [69] and cell cycle profiles
determined by flow cytometry analysis (Fig. 6C). Overall there was
no significant difference between the three shLRPPRC cell lines
and the NS cells. The profile of the 2.7 cells was similar to the
293T.NS cells, and the 3.6 and 4.1 cell lines exhibited only a slight
increase in cells in the G2 phase complemented by a slight
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decrease in cells in S phase compared to the 293T.NS cells. The
lack of a substantial effect of LRPPRC knockdown on cell cycle
profile suggested that cell cycle arrest was not the reason for
delayed growth of shLRPPRC cells. Together, the analyses of the
shLRPPRC cell lines indicated that the depletion of nuclear
LRPPRC resulted in a decrease in cellular proliferation without a
substantial reduction or abnormality in cell cycle phenotype.

accumulation in PML-bodies (P-bodies) [63]. Consistent with this
study, the level of nuclear eIF4E protein was reduced in the 3.6
and 4.1 cell lines, but not the 2.7 cells. Moreover, the 3.6 and 4.1
cell lines grew at a slower rate and exhibited a substantial
reduction in the proliferation factor c-Myc. The loss of nuclear
eIF4E and the strong reduction in c-Myc levels in these cell lines
likely contributed to the loss of proliferation compared to the NS
or 2.7 cell lines. Consistent with previous studies, MLV infectivity,
which is dependent on cell division, was reduced only in the 3.6
and 4.1 cell lines. HIV-1 infection is not prohibited in growtharrested cells. Therefore the loss of nuclear LRPPRC resulted in a
loss of viral DNA nuclear import via a distinct mechanism.
Additional studies will be needed to determine whether it is the
loss of LRPPRC or its associated factors that hinder the early steps
of HIV infection by investigating the loss of eIF4E and c-Myc
independently.
The other ascribed functions of LRPPRC provide additional
means through which its depletion could impact HIV-1 infection.
LRPPRC interacts with both RNA and DNA [57,58,59]. HIV
replication is regulated extensively at the RNA level and numerous
studies implicated RNA processing factors such as the serine/
arginine-rich family of proteins as critical for HIV-1 infection
[73,74]. These proteins are vital for mRNA nuclear export,
nonsense-mediated decay, and mRNA translation. Moreover, the
perturbation of eIF4E, a critical regulator of other transcription or
translation factors including Cyclin D1, and Pim-1, may also result
in an inhibition of HIV-1 infection.
Finally, the loss of mitochondrial LRPPRC may also contribute
to the reduction of HIV-1 infection. The majority of the data
suggests that LRPPRC is primarily a mitochondrial associated
protein [57,62,64] and new evidence confirm that it is required for
translation of mitochondrial mRNAs [75]. In addition to proper
mitochondrial function and gene expression [61], LRPPRC is
essential for COX I and III mRNA expression [62], and
phosphoenolpyruvate carboxykinase and glucose-6-phosphate
expression [60]. LRPPRC-depleted MCH58 fibroblast cells
exhibit decreased expression of three mitochondrial gene sets:
O-glycan biosynthesis, glycosphingolipid biosynthesis, and glycosphingolipid metabolism [76]. The effect of perturbing mitochondrial function on HIV-1 infection is not known, but it is clear that
virus infection alters mitochondrial function. Two independent
proteomic analyses observed the up-regulated expression of
proteins associated with mitochondria, the TCA cycle, fatty acid
oxidation, and oxidative phosphorylation in response to HIV-1
infection [67,77]. Thus LRPPRC reduction could negatively
impact HIV-1 infection by altering mitochondrial health and
reducing the function of critical metabolic pathways to a level that
does not support efficient virus replication.
A significant reduction of mitochondrial LRPPRC was observed
in the 3.6 and 4.1 shRNA cell lines. Despite this, there was no
measurable disruption of mitochondrial function in the cells as
measured by MTT and JC-1 assays. These results indicate that
there was no correlation between the loss of infection and
mitochondrial function; however they do not exclude the
possibility that mitochondrial associated LRPPRC is critical for
HIV-1 infection. Over extended cell passages LRPPRC accumulated in the mitochondrial compartment in both the 3.6 and 4.1
cell lines (data not shown). This suggests that mitochondrial
LRPPRC may have a long half-life in this compartment.
Moreover, there was a reduction of the LRPPRC-associated
protein SLIRP in all three cell lines. SLIRP is important for
posttranscriptional mitochondrial mRNA expression and consequently oxidative phosphorylation [64,65]. Interestingly, this
primarily mitochondrial protein also binds the steroid receptor

Discussion
Retroviral replication is a complex interaction between virus
and host factors. These studies identified a new cellular protein,
LRPPRC, which is necessary for efficient HIV-1 infection.
LRPPRC was identified by mass spectrometry of IN- and MAprotein complexes at 4 hpi, using a biotin-labeling system [38].
LRPPRC, a nucleic acid binding protein [57,58,59], was
subsequently determined to interact with HIV-1 RNA and DNA
during the early steps of replication. Stable knockdown of
LRPPRC with three independent shRNAs reduced HIV-1
infection during the early phase of virus replication. Infection of
all three cell lines resulted in a reduction of PIC formation, and
viral DNA nuclear import was impaired in two of the cell lines.
LRPPRC expression was not required for efficient virus production or viral RNA encapsidation. Combined these data indicated
that LRPPRC depletion affects the early events of HIV-1 infection
by at least two mechanisms.
LRPPRC is a multifunctional protein involved in mitochondrial
gene expression and function, cell cycle progression, and RNA
regulation. Therefore it was not surprising that knockdown of
LRPPRC affected HIV in multiple ways. LRPPRC was detected
in the membrane/organelle, nuclear, and insoluble/cytoskeletal
fractions, but not the cytosol of cells. Surprisingly, there were
distinct patterns of LRPPRC expression and its associated factors
in subcellular compartments among the three different
shLRPPRC cell lines. In all three cell lines LRPPRC was reduced
in the insoluble/cyoskeletal fraction, and there was a loss of
membrane/organelle associated SLIRP. The 3.6 and 4.1 cell lines
showed a reduction of LRPPRC in the membrane/organelle
fraction and nuclei, a loss of nuclear eIF4E, and a loss of c-myc.
The 2.7 cells exhibited an only a slight reduction of LRPPRC in
the membrane/organelle fraction, but showed no change in the
expression of eIF4E or c-Myc. Thus, the 2.7 cell line has a unique
knockdown phenotype when compared to the 3.6 and 4.1 cell
lines.
The only defect of HIV replication identified in all shLRPPRC
cell lines was a loss of PIC formation. Hence, the loss of
cytoskeletal-associated LRPPRC correlates with a loss of PIC
formation and represents one mechanism affecting HIV-1
replication. Sequence analysis of LRPPRC identified a putative
SEC1 domain involved in cytoskeletal interaction [70], however
the function of cytoskeletal LRPPRC remains unknown. Disruption of the cytoskeleton reduces RTC function [71] and possibly
PIC stability through association with microtubules [72]. Delineation of the role of LRPPRC in this subcellular fraction will
provide insight into the mechanism of PIC inhibition.
Infection of the 3.6 and 4.1 cell lines resulted in an impairment
in the accumulation of 2-LTR circles in the nuclei of cells,
implying that nuclear LRPPRC is necessary for efficient nuclear
import of viral DNA. Nuclear LRPPRC regulates the expression
of mRNAs related to cell cycle progression through an interaction
with eIF4E [63]. eIF4E is a critical regulator of the mRNA export
of several cell cycle regulatory factors including Cyclin D1, Pim-1,
and c-Myc [63]. Knockdown of LRPPRC adversely affects eIF4E
mediated RNA export due to cytoplasmic retention of eIF4E and
PLoS ONE | www.plosone.org
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RNA activator which is an RNA species that acts as a nuclear
receptor coactivator [78]. As with eIF4E and c-Myc, individual
knockdown of SLIRP will need to be investigated to determine
what role it may play in HIV replication. Future examination of
SLIRP and additional metabolic indicators and/or a gene array
analysis of the shLRPPRC cells may reveal new pathways that are
critical for efficient HIV infection.
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